$MNOV 3 SEC Filings

Filed On	Filing
08 Aug 2023	Form 3: Lemerond Nicole, Director No securities owned
27 Jun 2022	Form 3: Kruger Jason J, Chief Financial Officer No securities owned
10 Aug 2021	Form 3: Paulin Douglas, Chief Financial Officer No securities owned
26 Apr 2021	Form 3: Gaeta Federico C.a., Chief Scientific Officer
21 Jan 2021	Form 3: 3D Investment Partners Pte. Ltd., 10% owner and 1 other Holds 5,502,047 shares of Common Stock
22 Oct 2020	Form 3: Beaver Carolyn, Director No securities owned
24 Jun 2020	Form 3: Stepanow Edward C Jr., Chief Financial Officer No securities owned
05 Jun 2018	Form 3: Reyes Carla, Chief Financial Officer No securities owned
13 Nov 2017	Form 3: Nagao Hideki, Director
31 Mar 2016	Form 3: Selhorn Ryan J, Chief Financial Officer No securities owned
10 Apr 2014	Form 3: Ishizaka Yoshio, Director Holds 5,000 shares of Common Stock
10 Apr 2014	Form 3: van den Boom Esther, Chief Financial Officer No securities owned
15 Jan 2014	Form 3: Nakata Kousuke, Director Holds 800,000 shares of Common Stock, $0.001 par value
17 Oct 2013	Form 3: OBrien Geoffrey, Vice President Holds 5,000 shares of Common Stock
17 Oct 2013	Form 3: Kobayashi Yutaka, Director No securities owned
20 May 2013	Form 3: Satomi Hajime, 10% owner Holds 467,000 shares of Common Stock
12 Apr 2012	Form 3: O'Toole David D, Director No securities owned
18 Oct 2011	Form 3: Kissei Pharmaceutical Co., Ltd., 10% owner Holds 800,000 shares of Common Stock ($0.001 par value)
27 Sep 2011	Form 3: Matsuda Kazuko, Chief Medical Officer Holds 13,805 shares of Common Stock
27 Sep 2011	Form 3: Izumi Tatsuo, Director Holds 613,200 shares of Common Stock

Comments